Anastrozole and fulvestrant combo better than single drug for metastatic breast cancer
13:00 EDT 1 Aug 2012 | Medical Xpress
Results of a SWOG clinical trial published August 2 in the New England Journal of Medicine show the combination of anastrozole and fulvestrant extended the median survival time of women with hormone receptor-positive metastatic breast cancer by more..
Original Article: Anastrozole and fulvestrant combo better than single drug for metastatic breast cancer
More From BioPortfolio on "Anastrozole and fulvestrant combo better than single drug for metastatic breast cancer"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
